All News

Large studies do not support an association

Both direct and indirect evidence support this hypothesis.

This study was carried out to identify risk factors associated with urinary incontinence in women three months after giving birth.

Women need thorough and accurate information about the entire array of contraceptive options--new and old--so they can find their ideal method. Adherence--not efficacy--is the problem, and the hope is that greater choice will translate into fewer unintended pregnancies.

Bladder shape and size are clues to the etiology and extent of hydronephrosis. Knowing whether a lesion is likely to resolve on its own or respond to in utero treatment can make the difference between a positive and a negative postnatal outcome.

Boosting a patient's oxygen intake and maintaining normal body heat during and after ob/gyn surgery may cut the postop infection rate.

This bimonthly series is aimed at educating physicians on the pertinent aspects of litigation. Each case study provides analysis of an actual ob/gyn lawsuit defended by the New York firm of Aaronson, Rappaport, Feinstein & Deutsch, LLP.

The second installment in our two-part article on AIs looks at these agents as potential alternatives to clomiphene citrate and gonadotropins for stimulating fertility in breast cancer survivors.

Antibiotics can prove invaluable in the treatment of mastitis, but before you prescribe them, it's important to distinguish breast engorgement from infectious mastitis.

Does maternal epilepsy increase the risk of congenital malformations, or are the antiepileptic drugs to blame? Either way, the primary goal of therapy during pregnancy is to control a woman's seizures while minimizing fetal exposure to anticonvulsive drugs.

Case studies in coding gives practical advice on reimbursement.

Repeat C/S is not mandatory for all

Repeat C/S is not mandatory for all

Analgesics are everywhere, but that doesn't mean they're without risk. This timely review offers a balanced assessment of which ones pose the greatest threat.

Patients should have the option of elective repeat C/S

With new research showing that aromatase inhibitors can dramatically cut the risk of recurring breast cancer, patients will probably have many questions about drugs like anastrozole and letrozole. Two experts review the scientific evidence on these valuable agents.

Practicing obstetrics today requires not only the latest clinical knowledge but also patient- and people-management skills that can help minimize perinatal and maternal risk and reduce your legal exposure.